title: Doxorubicin chemotherapy affects intracellular and interstitial nitric oxide concentrations in skeletal muscle : Effect of doxorubicin on intracellular and interstitial NO in skeletal muscle.
abstract: The role of nitric oxide (NO) in doxorubicin (DOX; cancer chemotherapeutic)-induced cardiotoxicity is well established. In skeletal muscle (SM), NO regulation plays a critical role in health, biogenesis, and function. Despite the increasing evidence that indicates the negative impact of DOX on SM function, the effect of DOX on NO production in SM has yet to be examined. The purpose of the current study was to simultaneously examine intracellular and interstitial NO concentrations in the SM following the administration of DOX. A single dose of 1.5 or 4.5 mg/kg was administered intraperitoneally to male Sprague Dawley rats, and interstitial (IS) and intracellular (IC) NO was quantified every 24 up to 192 h post-injection. There was no significant difference in IC NO following the injection of 1.5 mg/kg DOX when compared to the control; however, the administration of 4.5 mg/kg DOX resulted in lower (P < 0.05) concentrations of NO in the IC. Interestingly, a consistently higher (P < 0.05) concentration of NO in the IS was established following the administration of 1.5 mg/kg compared to the control while no significant changes in IS NO resulted from the administration of the 4.5 mg/kg dose. The fluctuation of IS and IC NO was not a result of substrate availability as arginine concentrations remained stable throughout the experiment. By utilizing the microdialysis technique, we have simultaneously quantified for the first time the IS and IC concentrations of NO in SM following DOX administration. These data provide important insight in the possible mechanisms leading to DOX-related SM dysfunction.
authors.affiliation: Biomolecular Sciences, Laurentian University, Sudbury, Ontario, Canada. fabris.sergio@gmail.com.
authors.forename: Sergio
authors.initials: S
authors.lastname: Fabris
authors.affiliation: Biomolecular Sciences, Laurentian University, Sudbury, Ontario, Canada.|Division of Medical Sciences, Northern Ontario School of Medicine, Laurentian University Campus, 935 Ramsey Lake Road, Sudbury & Thunder Bay, Ontario, P3E 2C6, Canada.
authors.forename: David A
authors.initials: DA
authors.lastname: MacLean
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000494:pharmacology; D003593:Cytoplasm / Q000378:metabolism; D004317:Doxorubicin / Q000494:pharmacology*; D045604:Extracellular Fluid / Q000378:metabolism; D007424:Intracellular Fluid / Q000378:metabolism; D008297:Male; D018482:Muscle, Skeletal / Q000187:drug effects* / Q000378:metabolism*; D009569:Nitric Oxide / Q000378:metabolism*; D052247:Nitric Oxide Synthase Type II / Q000378:metabolism; D018384:Oxidative Stress / Q000187:drug effects; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D000975:Antioxidants; D009569:Nitric Oxide; D004317:Doxorubicin; D052247:Nitric Oxide Synthase Type II
keywords: Doxorubicin; Interstitial space; Nitric oxide; Skeletal muscle